{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:52:32Z","timestamp":1794012752444,"version":"4.8.0"},"reference-count":50,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["DI 2014 0192 44"],"award-info":[{"award-number":["DI 2014 0192 44"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T regulatory (Treg) cells play a critical role in the maintenance of self-tolerance, as well as in inhibition of inflammation and exaggerated immune response against exogenous antigens. They develop in the thymus (tTreg cells) but also may be generated at the peripheral tissues, including tumor microenvironment (pTreg cells), or induced in vitro in the presence of transforming growth factor (TGF)-\u03b2 (iTreg cells). Since tTreg cells constitute a minor fraction of peripheral blood lymphocytes in physiological conditions, an alternative way to obtain high number of functional Treg cells for therapeutic purposes is their generation in vitro from conventional T cells. In our studies, we compared effectiveness of several pharmacological agents with suggested immunomodulatory effects on Treg development (rapamycin, prednisolone, inosine pranobex, glatiramer acetate, sodium butyrate, and atorvastatin) to optimize Treg-inducing protocols. All but one (atorvastatin) immunomodulators augmented induction of polyclonal Treg cells in cultures. They were effective both in increasing the number of CD4\n                    <jats:sup>+<\/jats:sup>\n                    CD25\n                    <jats:sup>high<\/jats:sup>\n                    Foxp3\n                    <jats:sup>high<\/jats:sup>\n                    cells and Foxp3 expression. Rapamycin and prednisolone were found the most effective. Both drugs prolonged also phenotypic stability of Treg cells and induced fully active Treg cells in a functional assay. In the assay, prednisolone appeared superior versus rapamycin. The results, on the one hand, may be helpful in planning optimal protocols for generation of Treg cells for clinical application and, on the other hand, shed some light on mechanisms of the immunomodulatory activity of some tested agents observed in vivo.\n                  <\/jats:p>","DOI":"10.1007\/s00005-020-00582-6","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:02:47Z","timestamp":1591963367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin"],"prefix":"10.2478","volume":"68","author":[{"given":"Micha\u0142","family":"Janyst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Janyst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Zago\u017cd\u017con","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Kozlowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6156-055X","authenticated-orcid":false,"given":"Witold","family":"Lasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ni.2554","volume":"14","author":"AK Abbas","year":"2013","unstructured":"Abbas AK, Benoist C, Bluestone JA et al (2013) Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 14:307\u2013308","journal-title":"Nat Immunol"},{"key":"582_CR2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jcyt.2016.06.012","volume":"18","author":"A Alsuliman","year":"2016","unstructured":"Alsuliman A, Appel SH, Beers DR et al (2016) A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy 18:1312\u20131324","journal-title":"Cytotherapy"},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451\u2013455","journal-title":"Nature"},{"key":"582_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.celrep.2014.03.004","volume":"7","author":"O Bereshchenko","year":"2014","unstructured":"Bereshchenko O, Coppo M, Bruscoli S et al (2014) GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-\u03b2 signaling. Cell Rep 7:464\u2013475","journal-title":"Cell Rep"},{"key":"582_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00005-017-0469-3","volume":"65","author":"K Bocian","year":"2017","unstructured":"Bocian K, Kiernozek E, Domaga\u0142a-Kulawik J et al (2017) Expanding diversity and common goal of regulatory T and B cells. I: Origin, phenotype, mechanisms. Arch Immunol Ther Exp 65:501\u2013520","journal-title":"Arch Immunol Ther Exp"},{"key":"582_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-198632050-00001","volume":"32","author":"DM Campoli-Richards","year":"1986","unstructured":"Campoli-Richards DM, Sorkin EM, Heel RC (1986) Inosine Pranobex. Drugs 32:383\u2013424","journal-title":"Drugs"},{"key":"582_CR7","doi-asserted-by":"crossref","first-page":"e0182009","DOI":"10.1371\/journal.pone.0182009","volume":"12","author":"E Candia","year":"2017","unstructured":"Candia E, Reyes P, Covian C et al (2017) Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells. PLoS ONE 12:e0182009","journal-title":"PLoS ONE"},{"key":"582_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335:2\u201313","journal-title":"Mol Cell Endocrinol"},{"key":"582_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.intimp.2014.12.021","volume":"24","author":"D Fanigliulo","year":"2015","unstructured":"Fanigliulo D, Lazzerini PE, Capecchi PL et al (2015) Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans. Int Immunopharmacol 24:276\u2013284","journal-title":"Int Immunopharmacol"},{"key":"582_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.2012.02740.x","volume":"76","author":"B Fontenelle","year":"2012","unstructured":"Fontenelle B, Gilbert KM (2012) n-Butyrate anergized effector CD4 + T cells independent of regulatory T cell generation or activity. Scand J Immunol 76:457\u2013463","journal-title":"Scand J Immunol"},{"key":"582_CR11","first-page":"167086","volume":"2013","author":"DA Forero-Pe\u00f1a","year":"2013","unstructured":"Forero-Pe\u00f1a DA, Gutierrez FR (2013) Statins as modulators of regulatory T-cell biology. Mediators Inflamm 2013:167086","journal-title":"Mediators Inflamm"},{"key":"582_CR12","doi-asserted-by":"crossref","first-page":"102191","DOI":"10.18632\/oncotarget.22188","volume":"8","author":"XQ Fu","year":"2017","unstructured":"Fu XQ, Cai JY, Huang QY et al (2017) Prednisone may induce immunologic tolerance by activating the functions of decidual immune cells in early pregnancy. Oncotarget 8:102191\u2013102198","journal-title":"Oncotarget"},{"key":"582_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/chromsci\/43.4.201","volume":"43","author":"MN Gai","year":"2005","unstructured":"Gai MN, Pinilla E, Paulos C et al (2005) Determination of prednisolone and prednisone in plasma, whole blood, urine, and bound-to-plasma proteins by high-performance liquid chromatography. J Chromatogr Sci 43:201\u2013206","journal-title":"J Chromatogr Sci"},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gene.2011.77","volume":"13","author":"Y Gao","year":"2012","unstructured":"Gao Y, Lin F, Su J et al (2012) Molecular mechanisms underlying the regulation and functional plasticity of FOXP3+ regulatory T cells. Genes Immun 13:1\u201313","journal-title":"Genes Immun"},{"key":"582_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40259-017-0228-3","volume":"31","author":"M Gliwi\u0144ski","year":"2017","unstructured":"Gliwi\u0144ski M, Iwaszkiewicz-Grze\u015b D, Trzonkowski P (2017) Cell-based therapies with T regulatory cells. BioDrugs 31:335\u2013347","journal-title":"BioDrugs"},{"key":"582_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12872-016-0201-y","volume":"16","author":"L Guasti","year":"2016","unstructured":"Guasti L, Maresca AM, Schembri L et al (2016) Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment. BMC Cardiovasc Disord 16:26","journal-title":"BMC Cardiovasc Disord"},{"key":"582_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2009.06.011","volume":"216","author":"J Haas","year":"2009","unstructured":"Haas J, Korporal M, Balint B et al (2009) Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis. J Neuroimmunol 216:113\u2013117","journal-title":"J Neuroimmunol"},{"key":"582_CR18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","volume":"11","author":"KL Hippen","year":"2011","unstructured":"Hippen KL, Merkel SC, Schirm DK et al (2011) Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant 11:1148\u20131157","journal-title":"Am J Transplant"},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","volume":"102","author":"J Hong","year":"2005","unstructured":"Hong J, Li N, Zhang X et al (2005) Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci USA 102:6449\u20136454","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","volume":"29","author":"DA Horwitz","year":"2008","unstructured":"Horwitz DA, Zheng SG, Gray JD (2008) Natural and TGF-\u03b2\u2013induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends Immunol 29:429\u2013435","journal-title":"Trends Immunol"},{"key":"582_CR21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","volume":"114","author":"C Karagiannidis","year":"2004","unstructured":"Karagiannidis C, Akdis M, Holopainen P et al (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425\u20131433","journal-title":"J Allergy Clin Immunol"},{"key":"582_CR22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","volume":"6","author":"K Kretschmer","year":"2005","unstructured":"Kretschmer K, Apostolou I, Hawiger D et al (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219\u20131227","journal-title":"Nat Immunol"},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","volume":"4","author":"Q Lan","year":"2012","unstructured":"Lan Q, Fan H, Quesniaux V et al (2012) Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4:22\u201328","journal-title":"J Mol Cell Biol"},{"key":"582_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/acph-2015-0015","volume":"65","author":"W Lasek","year":"2015","unstructured":"Lasek W, Janyst M, Wolny R et al (2015) Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharm 65:171\u2013180","journal-title":"Acta Pharm"},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/eji.201142317","volume":"42","author":"JH Lee","year":"2012","unstructured":"Lee JH, Lydon JP, Kim CH (2012) Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur J Immunol 42:2683\u20132696","journal-title":"Eur J Immunol"},{"key":"582_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000477181","volume":"137","author":"SA Lee","year":"2017","unstructured":"Lee SA, Noel S, Sadasivam M et al (2017) Role of immune cells in acute kidney injury and repair. Nephron 137:282\u2013286","journal-title":"Nephron"},{"key":"582_CR27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19:373\u2013379","journal-title":"Cell Metab"},{"key":"582_CR28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu W, Putnam AL, Xu-yu Z et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med 203:1701\u20131711","journal-title":"J Exp Med"},{"key":"582_CR29","doi-asserted-by":"crossref","first-page":"E3432","DOI":"10.1073\/pnas.1408780111","volume":"111","author":"L Lu","year":"2014","unstructured":"Lu L, Lan Q, Li Z et al (2014) Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 111:E3432\u20133440","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5114\/ceji.2015.56960","volume":"40","author":"A Majewska","year":"2015","unstructured":"Majewska A, Lasek W, Janyst M et al (2015) Inhibition of adenovirus multiplication by inosine pranobex and interferon \u03b1 in vitro. Cent Eur J Immunol 40:395\u2013399","journal-title":"Cent Eur J Immunol"},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fped.2017.00117","volume":"5","author":"E Mart\u00edn-Orozco","year":"2017","unstructured":"Mart\u00edn-Orozco E, Norte-Mu\u00f1oz M, Mart\u00ednez-Garc\u00eda J (2017) Regulatory T cells in allergy and asthma. Front Pediatr 5:117","journal-title":"Front Pediatr"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","volume":"8","author":"JM Mathew","year":"2018","unstructured":"Mathew JM, Voss J, LeFever A et al (2018) A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants. Sci Rep 8:7428","journal-title":"Sci Rep"},{"key":"582_CR33","doi-asserted-by":"crossref","first-page":"e0143689","DOI":"10.1371\/journal.pone.0143689","volume":"10","author":"A Mathian","year":"2015","unstructured":"Mathian A, Jouenne R, Chader D et al (2015) Regulatory T cell responses to high-dose methylprednisolone in active systemic lupus erythematosus. PLoS ONE 10:e0143689","journal-title":"PLoS ONE"},{"key":"582_CR34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","volume":"197","author":"K Mausner-Fainberg","year":"2008","unstructured":"Mausner-Fainberg K, Luboshits G, Mor A et al (2008) The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 197:829\u2013839","journal-title":"Atherosclerosis"},{"key":"582_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.msard.2017.08.003","volume":"18","author":"DD Mitsikostas","year":"2017","unstructured":"Mitsikostas DD, Goodin DS (2017) Comparing the efficacy of disease-modifying therapies in multiple sclerosis. Mult Scler Relat Disord 18:109\u2013116","journal-title":"Mult Scler Relat Disord"},{"key":"582_CR36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","volume":"37","author":"N Ohkura","year":"2012","unstructured":"Ohkura N, Hamaguchi M, Morikawa H et al (2012) T Cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37:785\u2013799","journal-title":"Immunity"},{"key":"582_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.11.034","volume":"747","author":"PC Olsen","year":"2015","unstructured":"Olsen PC, Kitoko JZ, Ferreira TP et al (2015) Glucocorticoids decrease Treg cell numbers in lungs of allergic mice. Eur J Pharmacol 747:52\u201358","journal-title":"Eur J Pharmacol"},{"key":"582_CR38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T et al (2008) Regulatory T cells and immune tolerance. Cell 133:775\u2013787","journal-title":"Cell"},{"key":"582_CR39","doi-asserted-by":"crossref","first-page":"e24345","DOI":"10.1371\/journal.pone.0024345","volume":"6","author":"S Sbiera","year":"2011","unstructured":"Sbiera S, Dexneit T, Reichardt SD et al (2011) Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS ONE 6:e24345","journal-title":"PLoS ONE"},{"key":"582_CR40","doi-asserted-by":"crossref","first-page":"e0148474","DOI":"10.1371\/journal.pone.0148474","volume":"11","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Eriksson M, Shang MM et al (2016) Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate. PLoS ONE 11:e0148474","journal-title":"PLoS ONE"},{"key":"582_CR41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2013.00152","volume":"4","author":"EG Schmitt","year":"2013","unstructured":"Schmitt EG, Williams CB (2013) Generation and function of induced regulatory T cells. Front Immunol 4:152","journal-title":"Front Immunol"},{"key":"582_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trim.2012.09.003","volume":"27","author":"N Seissler","year":"2012","unstructured":"Seissler N, Schmitt E, Hug F et al (2012) Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR+-Treg-cells in transplanted patients. Transpl Immunol 27:157\u2013161","journal-title":"Transpl Immunol"},{"key":"582_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2017.06.006","volume":"181","author":"M Spadaro","year":"2017","unstructured":"Spadaro M, Montarolo F, Perga S et al (2017) Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10 years in responder multiple sclerosis patients. Clin Immunol 181:83\u201388","journal-title":"Clin Immunol"},{"key":"582_CR44","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.4049\/jimmunol.175.11.7380","volume":"175","author":"P Stock","year":"2005","unstructured":"Stock P, Akbari O, DeKruyff RH et al (2005) Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 175:7380\u20137387","journal-title":"J Immunol"},{"key":"582_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","volume":"133","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski P, Bieniaszewska M, Ju\u015bci\u0144ska J et al (2009a) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2212 T regulatory cells. Clin Immunol 133:22\u201326","journal-title":"Clin Immunol"},{"key":"582_CR46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cyto.a.20659","volume":"75","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski P, Szary\u0144ska M, My\u015bliwska J et al (2009b) Ex vivo expansion of CD4 + CD25 + T regulatory cells for immunosuppressive therapy. Cytom A 75:175\u2013188","journal-title":"Cytom A"},{"key":"582_CR47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","volume":"37","author":"J Wang","year":"2007","unstructured":"Wang J, Ioan-Facsinay A, van der Voort EIH et al (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37:129\u2013138","journal-title":"Eur J Immunol"},{"key":"582_CR48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41590-019-0351-z","volume":"20","author":"N Whibley","year":"2019","unstructured":"Whibley N, Tucci A, Powrie F (2019) Regulatory T cell adaptation in the intestine and skin. Nat Immunol 20:386\u2013396","journal-title":"Nat Immunol"},{"key":"582_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00005-018-0530-x","volume":"67","author":"A Zahran","year":"2019","unstructured":"Zahran A, Saad K, Abdel-Raheem YF et al (2019) Characterization of regulatory T cells inpreterm and term infants. Arch Immunol Ther Exp 67:49\u201354","journal-title":"Arch Immunol Ther Exp"},{"key":"582_CR50","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4049\/jimmunol.169.8.4183","volume":"169","author":"SG Zheng","year":"2002","unstructured":"Zheng SG, Gray JD, Ohtsuka K et al (2002) Generation ex vivo of TGF-\u03b2-producing regulatory T cells from CD4+ CD25\u2212 precursors. J Immunol 169:4183\u20134189","journal-title":"J Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-020-00582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:49:25Z","timestamp":1704210565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-020-00582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s00005-020-00582-6","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"20"}}